Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting NCT07278492 Sponsor: Brigham and Women's Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 1 Alzheimer's Disease Trial, Not Yet Recruiting

NCT07278492
Not Yet Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with Down syndrome caused by a full extra copy of chromosome 21 (trisomy 21) or a related chromosomal change, confirmed by a genetic test or medical records
  • You are 18 years old or older
  • You have a caregiver or someone who knows you well, who spends more than 10 hours per week with you and can answer questions about your health
  • You (or your legal representative) are able to understand what the study involves and are willing to sign a consent form and complete the study activities
  • If you are female, you are not currently pregnant and do not plan to become pregnant in the next 6 months

Who may not be able to join:

  • Your urine shows very high levels of a protein called albumin (above a certain threshold on a kidney health test) (confirm with trial site)
  • Your liver enzyme levels (AST or ALT) are significantly above the normal range on a blood test
  • Your kidneys are not filtering blood well enough, based on a blood test result
  • Your blood's red cell level (hematocrit) is too low or too high
  • You have had a serious heart or cardiovascular event (such as a heart attack or stroke) in the past 3 months
  • You have taken part in another drug or biological treatment trial in the past 3 months
  • You currently have a problem with alcohol or drug use or dependence
  • You have certain mental health conditions, such as major depression, bipolar disorder, schizophrenia, or current symptoms that could make it hard to take part in the study
  • You have been hospitalised for a serious illness, including COVID-19, in the past 3 months, or have had any acute illness including COVID-19 in the past month
  • You have previously had a severe allergic reaction (anaphylaxis) to vitamin B3 or related substances
  • Your body mass index (BMI) is above 42.5 (confirm with trial site)
  • You are unable to walk

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Shalender K Bhasin, MB, BS, Brigham and Women's Hosptial

Phone: 6179999195

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 1
Registry
ClinicalTrials.gov
Start date
31 July 2026
Est. completion
31 March 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Treatment emergent adverse events; Treatment emergent serious adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov